Defence Therapeutics Inc.
DTC
Ранг среди акций
#29262
Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a... Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a biotechnology company founded in 2017. This firm focuses on pioneering biological and biosimilar therapeutic solutions for both cancer and infectious diseases. A cornerstone of its approach is the exclusive ACCUM™ technology, engineered to precisely and safely transport vaccine antigens or antibody-drug conjugates (ADCs) directly to their intended cellular targets. The company's development efforts span several key areas: novel dendritic cell vaccines for various cancers, protein-based vaccines addressing COVID-19 and other infectious ailments, and specialized antibody-drug conjugate products aimed at different cancer types. Defence Therapeutics Inc. adopted its current name in March 2020, having previously operated as Accum Therapeutics Inc.
Цена акции
$0.26788696
Рыночная капитализация
$20.30M
Изменение (1 день)
-3.95%
Изменение (1 год)
-54.23%
Страна
CA
Торговля Defence Therapeutics Inc. (DTC)
Категория
Healthcare
Коэффициент P/B для Defence Therapeutics Inc. (DTC)
Коэффициент P/B на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Defence Therapeutics Inc., текущий коэффициент P/B (TTM) составляет 0. В конце 2026 он составлял 0.
История P/B для Defence Therapeutics Inc. с 2026 по 2026
Коэффициент P/B в конце каждого года
| Год | P/B | Изменить |
|---|---|---|
| Недостаточно данных для указанных дат. | ||
Коэффициент P/B для аналогичных компаний или конкурентов
| Компания | P/B | Разница P/B | Страна |
|---|---|---|---|
| 6.251 | - |
US
|
|
| 13.2547 | - |
US
|
|
| 4.208 | - |
AU
|
|
| - | - |
CH
|
|
| 6.1824 | - |
NL
|
